Changes in the biological: Immunological ratio of basal and GnRH-releasable FSH during the follicular, pre-ovulatory and luteal phases of the human menstrual cycle

Human Reproduction

Volumn 16, Issue 8, 2001, Pages 1611-1618

  Zarinan T ^a   Olivares, A ^b   Soderlund D ^b   Mendez J P ^b   Ulloa Aguirre, A ^a  

^a INSTITUTO MEXICANO DEL SEGURO SOCIAL   (Mexico)

^b HOSPITAL DE PEDIATRÍA   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

ESTRADIOL; FOLLITROPIN; FOLLITROPIN RECEPTOR; GONADORELIN; LUTEINIZING HORMONE; PROGESTERONE;

ADENOHYPOPHYSIS; ADULT; ARTICLE; BLOOD SAMPLING; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; ENDOCRINE SYSTEM; FEMALE; FOLLICULAR PHASE; FOLLITROPIN BLOOD LEVEL; FOLLITROPIN RELEASE; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; IMMUNOASSAY; IN VITRO STUDY; LUTEAL PHASE; MENSTRUAL CYCLE; NORMAL HUMAN; OVARY FOLLICLE MATURATION; OVULATION; SERUM; SIGNAL TRANSDUCTION;

EID: 0034882814     PISSN: 02681161     EISSN: None     Source Type: Journal    
DOI: 10.1093/humrep/16.8.1611     Document Type: Article

References (64)

1. Glycoform composition of serum gonadotrophins through the normal menstrual cycle and in the post-menopausal state
2. Activation of extracellular-regulated kinase pathways in ovarian granulosa cells by the novel growth factor type 1 follicle-stimulating hormone receptor
3. Pituitary glycoprotein hormone oligosaccharides: Structure, synthesis and function of asparagine linked oligosaccharides on lutropin, follitropin and thyrotropin
4. Assessment of the in vitro and in vivo biological activities of the human follicle-stimulating hormone isohormones
5. Specific roles for the asparagine-linked carbohydrate residues of recombinant human follicle stimulating hormone in receptor binding and signal transduction
6. Both of the (-subunit carbohydrate residues of follicle-stimulating hormone determine the metabolic clearance rate and in vivo potency
7. Structural features of mammalian gonadotrophins
8. A preponderance of circulating basic isoforms is associated with decreased plasma half-life and biological to immunological ratio of gonadotropin-releasing hormone-releasable luteinizing hormone in obese men
9. Isoelectric charge of recombinant human follicle-stimulating hormone isoforms determines receptor affinity and in vitro bioactivity
10. Homologous in vitro bioassay for follicle-stimulating hormone (FSH) reveals increased FSH biological signal during the mid- to late luteal phase of the human menstrual cycle
11. Human FSH isoforms: Carbohydrate complexity as determinant of in vitro bioactivity
12. Naturally occurring antihormones: Secretion of FSH antagonists by women treated with a GnRH analog
13. Oestrogens regulate pituitary (2,3-sialytransferase messenger ribonucleic acid levels in the female rat
14. Simultaneous analysis of families of sigmoidal curves: Application to bioassay, radioligand assay and physiological dose-response curves
15. Estrogen modulates expression of the glycosyltransferases that synthesize sulfated oligosaccharides on lutropin
16. The role of the asparagine-linked oligosaccharides of the alpha- subunit in human thyrotropin bioactivity
17. Granulosa cell aromatase bioassay: Changes of bioactive FSH levels in the female
18. Increased biological activity due to basic isoforms in recombinant human follicle-stimulating hormone
19. Site-directed mutagenesis defines the individual roles of the glycosilation sites on follicle-stimulating hormone
20. Effects of oestradiol, phenobarbitone and luteinizing hormone releasing hormone upon the isoelectric profile of pituitary follicle-stimulating hormone in ovariectomized hamsters
21. Follicle-stimulating hormone (FSH) stimulates phosphorylation and activation of protein kinase B (PKB/Akt) and serum and glucocorticoid-induced kinase (Sgk): Evidence for A kinase-independent signaling by FSH in granulosa cells
22. Differential processing of Asn-linked oligosaccharides on pituitary glycoprotein hormones: Implications for biologic function
23. In vitro bioassay for human serum follicle-stimulating hormone (FSH) based on L cells transfected with recombinant rat FSH receptor: Validation of a model system
24. Serum bioactive follicle-stimulating hormone during the human menstrual cycle and in hyper- and hypogonadotropic states: Application of a sensitive granulosa cell aromatase bioassay
25. Comparative mapping of human thyrotropin, gonadotropin and free subunits with antipeptide antibodies
26. Gonadotropin heterogeneity and biopotency: Implications for assisted reproduction
27. Do immunoassays differentially detect different acidity glycoforms of FSH?
28. Modulation of serum follicle-stimulating hormone bioactivity and isoforms distribution by estrogenic steroids in normal women and in gonadal disgenesis
29. Follicle-stimulating hormone signal transduction: Role of carbohydrate in aromatase induction in immature rat Sertoli cells
30. Carbohydrate dependent epitope mapping of human thyrotropin
31. Differential effect of glycosylation on the expression of antigenic and bioactive domains in human thyrotropin
32. Changes in the isoforms of luteinizing hormone and follicle-stimulating hormone during puberty in normal children
33. Circulating bioactive follicle stimulating hormone and immunoreactive inhibin levels during the normal human menstrual cycle
34. The follicle-stimulating hormone (FSH) receptor in testis: Interaction with FSH, mechanism of signal transduction and properties of the purified receptor
35. The interpretation of immuno- and bioassays of human FSH
36. Role of carbohydrates in glycoprotein hormone signal transduction
37. Follitropin signal transduction: Alternative splicing of the FSH receptor gene produces a dominant negative form of the receptor which inhibits hormone action
38. In vitro bioassays of follicle-stimulating hormone: Methods and clinical applications
39. Polymorphism of human pituitary FSH: Analysis of immunoreactivity in vitro bioactivity of different molecular species
40. Isolation and physicochemical characterization of human follicle-stimulating hormone isoforms
41. Expression of recombinant human follicle-stimulating hormone receptor: Species-specific ligand binding signal transduction, and identification of multiple ovarian messenger ribonucleic acid transcripts
42. A naturally occurring basically charged human follicle-stimulating hormone (FSH) variant inhibits FSH-induced androgen aromatization and tissue-type plasminogen activator enzyme activity in vitro
43. Differential effects of the charge variants of human follicle-stimulating hormone
44. Effects of gonadotrophin-releasing hormone, recombinant human activin-A and sex steroid hormones upon the follicle-stimulating isohormones secreted by rat anterior pituitary cells in culture
45. Biological characterization of the naturally occurring analogues of intrapituitary human follicle-stimulating hormone
46. Follicle-stimulating isohormones: Characterization and physiological relevance
47. Role of glycosylation in function of follicle-stimulating hormone
48. Estrogen regulates the gonadotropin-releasing hormone-stimulated secretion of biologically active luteinizing hormone
49. Pathophysiological features of the pulsatile secretion of biologically active luteinizing hormone in man
50. Frequency modulation of follicle-stimulating hormone (FSH) during the luteal-follicular transition: Evidence for FSH control of inhibin B in normal women
51. Characterization of FSH secretory burst activity in normal women during the menstrual cycle
52. The functional changes of the pituitary gonadotropes during the menstrual cycle
53. Gonadotropin secretion in response to low, and high doses of LRF in normal and hypogonadal women (functional disparity of the gonadotrophs)
54. Median charge and charge heterogeneity of human pituitary FSH, LH and TSH. I. Zone electrophoresis in agarose suspension
55. Median charge and charge heterogeneity of human pituitary FSH, LH and TSH. II. Relationship to sex and age
56. The regulation of metabolic clearance rate of human FSH in mice by variation of the molecular structure of the hormone
57. Follicle-stimulating hormone in anterior pituitary glands from children and adults differ in relation to sex and age
58. More basic forms of both human follicle-stimulating hormone and luteinizing hormone in serum at midcycle compared with the follicular or luteal phase
59. 17β-Estradiol counteracts the formation of the more acidic isoforms of follicle-stimulating hormone and luteinizing hormone after menopause
60. Effect of chronic daily oral administration of 17β-oestradiol and norethisterone on the isoforms of serum gonadotrophins in post-menopausal women
61. Dynamics of basal and gonadotropin-releasing hormone-releasable serum follicle-stimulating hormone charge isoform distribution throughout the human menstrual cycle
62. Studies on the relative in vitro biological potency of the naturally occurring isoforms of intrapituitary follicle-stimulating hormone
63. Receptor binding activity and in vitro biological activity of the human FSH charge isoforms as disclosed by heterologous and homologous assay systems
64. Glycosylation is the structural basis for changes in polymorphism and immunoreactivity of pituitary glycoprotein hormones